3H's Hybridoma Cell Screening Technology
Hoʻohana maikaʻi kēia kahua i ka ʻenehana ʻike maka ʻana i ka protein array chip no ka nānā ʻana i nā antibodies monoclonal me ka kikoʻī kiʻekiʻe, ka pilina kiʻekiʻe a me ka hopena hana kiʻekiʻe e kūʻē i nā Epitopes kikoʻī mai nā antibodies i huna ʻia e nā cell hybridoma ma hope o ka ulu paʻa.
Hōʻike Protein a me ka ʻenehana hoʻomaʻemaʻe
Ma muli o ka hana paʻakikī o ka hoʻokaʻawale ʻana a me ka hoʻomaʻemaʻe antibody kahiko, ka maʻalahi o ka wehe ʻana o nā ligands a me nā mea hoʻopili chromatography affinity pipiʻi, ua kūkulu mākou i kahi ʻano hoʻokaʻawale antibody e pili ana i nā microspheres magnetic a noi ʻia no kahi patent.Me kēia ʻenehana, hiki ke maʻalahi a maʻalahi ka hoʻokaʻawale ʻana i ka antibody mai ka wai hānai i loaʻa nā haumia paʻa, a hiki i ka antibody ke piʻi aku ma mua o 98% maʻemaʻe.
3H's Hybridoma Cell Screening Technology
Hoʻohana maikaʻi kēia kahua i ka ʻenehana ʻike maka ʻana i ka protein array chip no ka nānā ʻana i nā antibodies monoclonal me ka kikoʻī kiʻekiʻe, ka pilina kiʻekiʻe a me ka hopena hana kiʻekiʻe e kūʻē i nā Epitopes kikoʻī mai nā antibodies i huna ʻia e nā cell hybridoma ma hope o ka ulu paʻa.
Hōʻike Protein a me ka ʻenehana hoʻomaʻemaʻe
Ma muli o ka hana paʻakikī o ka hoʻokaʻawale ʻana a me ka hoʻomaʻemaʻe antibody kahiko, ka maʻalahi o ka wehe ʻana o nā ligands a me nā mea hoʻopili chromatography affinity pipiʻi, ua kūkulu mākou i kahi ʻano hoʻokaʻawale antibody e pili ana i nā microspheres magnetic a noi ʻia no kahi patent.Me kēia ʻenehana, hiki ke maʻalahi a maʻalahi ka hoʻokaʻawale ʻana i ka antibody mai ka wai hānai i loaʻa nā haumia paʻa, a hiki i ka antibody ke piʻi aku ma mua o 98% maʻemaʻe.
Mea Hana Hana Nui
Ua hoʻomohala ʻo Bioantibody i ka ʻenehana no ka hana antibody recombinant.Ma kēia kahua, ua hoʻohana ʻia ka ʻenehana Switching Mechanism ma 5'end of RNA Transcript (SMART) e hoʻonui i nā genes o ke kaulahao kaumaha a me ke kaulahao māmā o nā antibodies me ka maikaʻi.A laila e hoʻokō i ka transient transfection a me ka transfection paʻa, hiki ke hoʻohana ʻia ka hoʻololi kūpono a me ka ʻenehana fermentation hoʻololi paʻa.Ma kahi huaʻōlelo, hiki iā mākou ke hana i nā antibodies hana e like me nā koi o ka papahana.
Biopharmaceutical Development Technology
ʻO nā biopharmaceuticals nā ʻāpana cellular biological a i ʻole macromolecules.ʻO ia ka manawa a me ke kumu kūʻai no ka loaʻa ʻana o kahi lāʻau lapaʻau hou.Ma muli o nā ʻenehana hoʻomohala maikaʻi a me nā ʻenehana hoʻomohala antibody, ua kūkulu ʻo Bioantibody i kahi hui kūikawā a me kahi kahua no ka hoʻomohala biopharmaceutical, kahi e hōʻoia ai e hiki iā mākou ke hāʻawi i kā mākou huahana kiʻekiʻe a me nā lawelawe maʻamau i nā hui biomedicine.
Mea Hana Hana Nui
Ua hoʻomohala ʻo Bioantibody i ka ʻenehana no ka hana antibody recombinant.Ma kēia kahua, ua hoʻohana ʻia ka ʻenehana Switching Mechanism ma 5'end of RNA Transcript (SMART) e hoʻonui i nā genes o ke kaulahao kaumaha a me ke kaulahao māmā o nā antibodies me ka maikaʻi.A laila e hoʻokō i ka transient transfection a me ka transfection paʻa, hiki ke hoʻohana ʻia ka hoʻololi kūpono a me ka ʻenehana fermentation hoʻololi paʻa.Ma kahi huaʻōlelo, hiki iā mākou ke hana i nā antibodies hana e like me nā koi o ka papahana.
Biopharmaceutical Development Technology
ʻO nā biopharmaceuticals nā ʻāpana cellular biological a i ʻole macromolecules.ʻO ia ka manawa a me ke kumu kūʻai no ka loaʻa ʻana o kahi lāʻau lapaʻau hou.Ma muli o nā ʻenehana hoʻomohala maikaʻi a me nā ʻenehana hoʻomohala antibody, ua kūkulu ʻo Bioantibody i kahi hui kūikawā a me kahi kahua no ka hoʻomohala biopharmaceutical, kahi e hōʻoia ai e hiki iā mākou ke hāʻawi i kā mākou huahana kiʻekiʻe a me nā lawelawe maʻamau i nā hui biomedicine.